356 related articles for article (PubMed ID: 6803566)
1. Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.
Riegger GA; Steilner H; Hayduk K; Liebau G
Am J Cardiol; 1982 Apr; 49(6):1555-7. PubMed ID: 6803566
[TBL] [Abstract][Full Text] [Related]
2. Captopril treatment: inter-dose variations in renin, angiotensins I and II, aldosterone and blood pressure.
Atkinson AB; Cumming AM; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
Br J Clin Pharmacol; 1982 Jun; 13(6):855-8. PubMed ID: 7046776
[TBL] [Abstract][Full Text] [Related]
3. Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Atkinson AB; Morton JJ; Brown JJ; Davies DL; Fraser R; Kelly P; Leckie B; Lever AF; Robertson JI
Br Heart J; 1980 Sep; 44(3):290-6. PubMed ID: 7000102
[TBL] [Abstract][Full Text] [Related]
4. Effect of captopril on the renin-angiotensin system in hypertensive children.
Friedman AL; Chesney RW
J Pediatr; 1983 Nov; 103(5):806-10. PubMed ID: 6355422
[TBL] [Abstract][Full Text] [Related]
5. Hormonal changes with long-term converting-enzyme inhibition by captopril in essential hypertension.
Matthews PG; McGrath BP; Johnston CI
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():135s-138s. PubMed ID: 232017
[TBL] [Abstract][Full Text] [Related]
6. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
Goto A
Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
[TBL] [Abstract][Full Text] [Related]
7. Captopril in hypertension with renal artery stenosis and in intractable hypertension; acute and chronic changes in circulating concentrations of renin, angiotensins I and II and aldosterone, and in body composition.
Atkinson AB; Brown JJ; Fraser R; Leckie B; Lever AF; Morton JJ; Robertson JI
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():139s-143s. PubMed ID: 396067
[No Abstract] [Full Text] [Related]
8. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
Ueda Y; Honda M; Hatano M
Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
[TBL] [Abstract][Full Text] [Related]
9. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression.
Staessen J; Lijnen P; Fagard R; Verschueren LJ; Amery A
J Endocrinol; 1981 Dec; 91(3):457-65. PubMed ID: 7035596
[TBL] [Abstract][Full Text] [Related]
10. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
Rasmussen S; Damkjaer Nielsen M; Ibsen H; Leth A; Giese J
Eur J Clin Invest; 1984 Feb; 14(1):30-6. PubMed ID: 6321195
[TBL] [Abstract][Full Text] [Related]
11. Effect of infused captopril on blood pressure and the renin-angiotensin-aldosterone system in normal dogs subjected to varying sodium balance.
Morton JJ; Tree M; Casals-Stenzel J
Am J Cardiol; 1982 Apr; 49(6):1395-400. PubMed ID: 7041583
[TBL] [Abstract][Full Text] [Related]
12. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
[TBL] [Abstract][Full Text] [Related]
13. Primacy of the renin-angiotensin system in mediating the aldosterone response to sodium restriction.
Swartz SL; Williams GH; Hollenberg NK; Dluhy RG; Moore TJ
J Clin Endocrinol Metab; 1980 Jun; 50(6):1071-4. PubMed ID: 6989849
[TBL] [Abstract][Full Text] [Related]
14. [A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].
Overlack A; Stumpe KO; Heck I; Krück F
Dtsch Med Wochenschr; 1980 Apr; 105(15):505-9. PubMed ID: 6244920
[TBL] [Abstract][Full Text] [Related]
15. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
Atlas SA; Case DB; Yu ZY; Laragh JH
Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
[TBL] [Abstract][Full Text] [Related]
16. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
Weber MA; Drayer JI; Priest RT; Chen TC
Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
[TBL] [Abstract][Full Text] [Related]
17. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
Ohman KP; Karlberg BE; Nilsson OR; Wettre S
Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.
Johnston CI; Millar JA; McGrath BP; Matthews PG
Lancet; 1979 Sep; 2(8141):493-6. PubMed ID: 90216
[TBL] [Abstract][Full Text] [Related]
19. Fluctuations in the plasma angiotensin I converting enzyme activity during long-term treatment with captopril.
Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
Acta Cardiol; 1982; 37(1):1-9. PubMed ID: 6282024
[TBL] [Abstract][Full Text] [Related]
20. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
Shepherd AN; Campbell BC; Reid JL
J Cardiovasc Pharmacol; 1982; 4(3):381-7. PubMed ID: 6177933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
